#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2194	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2180	214.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1417	1417	C	389	C,G	266,3	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2194	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2180	214.8	0	HET	.	.	.	C451T	.	451	451	C	684	684	C	177	C,T	75,63	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2194	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2180	214.8	0	HET	.	.	.	C207T	.	207	207	C	440	440	C	209	C,T	118,35	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3462	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3761	195.9	0	.	n	.	0	T695C	SNP	695	695	T	1146	1146	C	290	C,T,A	199,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3462	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3761	195.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2422	2422	C	279	C,T	186,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3462	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3761	195.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2496	2496	A	261	A	184	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3462	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3761	195.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3048	3048	C	249	C,G	177,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3462	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3761	195.9	0	HET	.	.	.	A1638G	.	1638	1638	A	2089	2089	A	163	A,G	72,51	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	244	folP	855	855	100.0	folP.l15.c4.ctg.1	1915	28.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1180	1182	AGC	47;49;49	A;G;C	36;37;37	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	380	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3347	24.2	1	SNP	p	S91F	1	.	.	271	273	TTC	654	656	TTC	17;17;17	T;T;C	14;14;14	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	380	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3347	24.2	1	SNP	p	D95G	1	.	.	283	285	GGC	666	668	GGC	22;22;22	G;G;C	17;17;17	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	380	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3347	24.2	1	SNP	p	G95N	0	.	.	283	285	GGC	666	668	GGC	22;22;22	G;G;C	17;17;17	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	88	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1606	12.2	1	SNP	p	G45D	0	.	.	133	135	GGC	418	420	GGC	26;26;26	G;G;C	17;17;16	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	64	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	938	13.3	0	.	n	.	0	A197.	DEL	197	197	A	598	598	A	24	A	18	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	296	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3203	19.8	1	SNP	p	D86N	0	.	.	256	258	GAC	756	758	GAC	29;29;29	G;A;C	21;18;18	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	296	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3203	19.8	1	SNP	p	R87I	0	.	.	259	261	CGT	759	761	CGT	31;31;32	C;G;T	22;22;21	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	296	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3203	19.8	1	SNP	p	R87W	0	.	.	259	261	CGT	759	761	CGT	31;31;32	C;G;T	22;22;21	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	296	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3203	19.8	1	SNP	p	S87R	1	.	.	259	261	CGT	759	761	CGT	31;31;32	C;G;T	22;22;21	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	296	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3203	19.8	1	SNP	p	S88P	0	.	.	262	264	TCC	762	764	TCC	32;32;34	T;C;C	22;23;25	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	394	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2847	29.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1529	1531	GGC	18;18;19	G;G;C	15;14;16	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	366	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	29.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1382	1384	GCC	63;63;63	G;C;C,G	42;42;40,2	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	366	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	29.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1385	1387	ATG	63;62;61	A,T;T;G	41,1;41;41	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	366	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	29.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1397	1399	ACC	65;65;65	A;C;C	43;43;43	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	366	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	29.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1397	1399	ACC	65;65;65	A;C;C	43;43;43	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	366	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	29.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1898	1900	ACC	49;49;47	A;C;C	32;31;32	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	366	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	29.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1952	1954	GCG	41;41;41	G;C;G	29;26;28	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	366	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	29.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1952	1954	GCG	41;41;41	G;C;G	29;26;28	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	366	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	29.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2075	2077	GGT	20;20;18	G;G;T,G	15;15;12,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	366	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	29.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2084	2086	AGC	16;16;17	A;G;C	11;12;12	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	366	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2594	29.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2102	2104	CCG	11;11;11	C,G;C;G	7,2;8;8	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	468	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3130	30.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1699	1701	CCG	22;22;22	C;C;G,C	17;18;15,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	132	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1569	17.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	357	357	C	24	C	15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	22	porB1a	984	257	90.04	porB1a.l15.c4.ctg.1	942	4.8	0	.	p	.	0	H217N	NONSYN	649	651	CAT	710	712	AAT	10;10;10	A;A;T	7;7;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	22	porB1a	984	257	90.04	porB1a.l15.c4.ctg.1	942	4.8	0	.	p	.	0	D218N	NONSYN	652	654	GAT	713	715	AAT	10;10;10	A;A;T	7;7;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	22	porB1a	984	257	90.04	porB1a.l15.c4.ctg.1	942	4.8	0	.	p	.	0	V226A	NONSYN	676	678	GTA	737	739	GCA	9;9;9	G;C;A	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	22	porB1a	984	257	90.04	porB1a.l15.c4.ctg.1	942	4.8	0	.	p	.	0	.	MULTIPLE	700	702	ACT	760	762	GTA	9;9;9	G,T;T;A	5,1;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	22	porB1a	984	257	90.04	porB1a.l15.c4.ctg.1	942	4.8	0	.	p	.	0	N237fs	FSHIFT	709	709	A	769	769	A	9	A	6	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	164	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1754	19.9	1	SNP	p	G120K	1	.	.	358	360	AAG	711	713	AAG	24;24;26	A;A;G	21;22;23	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	164	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1754	19.9	1	SNP	p	N121D	0	.	.	361	363	AAC	714	716	AAC	26;26;26	A;A;C	23;24;23	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	164	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1754	19.9	1	SNP	p	A121N	1	.	.	361	363	AAC	714	716	AAC	26;26;26	A;A;C	23;24;23	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	836	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5174	34.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	72	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	990	15.4	1	SNP	p	V57M	1	.	.	169	171	ATG	779	781	ATG	25;25;25	A;T;G	18;18;18	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
